Treatment of DMARD Naive Patients With Poor Prognosis Rheumatoid Arthritis Using Rituximab: A Pilot Study Evaluating Synovial Outcomes.
Phase of Trial: Phase IV
Latest Information Update: 19 Mar 2012
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 19 Mar 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov.
- 19 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.